Clinical trial

Effectiveness of Focal Microvibration in the Management of Chronic Lumbosacral Radicular Pain: a Randomized Controlled Study

Name
PB001
Description
The goal of this clinical trial is to investigate the effectiveness of focal microvibration on patients affected by chronic lumbosacral radicular pain. The main question\[s\] it aims to answer are: * Can focal microvibration improve pain in this patient population? * Can focal microvibration improve quality of life in these patients? Participants will attach to their skin four little devices (10x20x0,5mm) delivering focal microvibration in the painful area according to researchers indications for 6 hours/day every day except Thursday and Sunday. Researchers will compare patients treated with focal microvibration to patients treated with a sham device and to patients treated with standard pharmacological therapy.
Trial arms
Trial start
2024-04-01
Estimated PCD
2025-10-01
Trial end
2026-04-01
Status
Not yet recruiting
Treatment
Equistasi®
Four devices will be attached to the skin according the indication of the investigators for 6 hours/day every day except Thursday and Sunday
Arms:
Patients treated with Focal Microvibration
Sham
Four devices similar to the active one but not able to deliver the microvibration will be applied to the patients
Arms:
Patients treated with a Sham device
Other names:
No active device
Gabapentin; Pregabalin; Duloxetine; Amitriptyline
Patients will be treated with drugs (gabapentinoids, Serotonin-norepinephrine reuptake inhibitor, tricyclic antidepressants, opioids) according to guidelines.
Arms:
Patients treated with standard pharmacological approach
Other names:
Drugs for neuropathic pain
Size
150
Primary endpoint
Pain intensity
12 months
Eligibility criteria
Inclusion Criteria: * Pain duration≥6 months * Magnetic resonance imaging (MRI) showing compression of lumbosacral nerve roots * Neuropathic symptoms in the innervation territory of the compressed spinal nerve roots * Monolateral pain * Pain intensity: moderate-severe i.e. numeric rating scale (NRS)≥4. Exclusion Criteria: * Psychiatric patients * Cancer patients * Patients affected by disease characterized by spasticity or muscular stiffness: Parkinson's disease, multiple sclerosis, stroke, spine injuries. * Patients with spinal or dorsal root ganglion stimulators * Patients undergone central of peripheral stimulation in the past 3 months * Patients affected by fibromyalgia. * Patients undergone central nervous system surgery * Patients with reduced renal function eGFR≤60ml/min/1,73m2
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'SINGLE', 'whoMasked': ['PARTICIPANT']}}, 'enrollmentInfo': {'count': 150, 'type': 'ESTIMATED'}}
Updated at
2024-03-08

1 organization

1 product

4 indications

Product
Gabapentin
Indication
Pain
Indication
Chronic
Indication
Sciatica
Indication
Radicular